Diagnostics giant cemented its leading role during the pandemic
Although the Covid-19 pandemic revolutionized the demand for diagnostics products, the players on the global market have maintained their respective positions. The biggest diagnostics companies have reaped the greatest rewards from the crisis, says the global CEO at Roche Diagnostics.
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN
As the Covid-19 pandemic spread rapidly across the globe, words like "PCR tests" and "antigen tests" became part of everyday vernacular, and the crucial importance of the diagnostics industry suddenly became frighteningly obvious to both citizens and politicians alike.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
